Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

137.21
-3.9000-2.76%
Post-market: 137.610.4019+0.29%19:55 EDT
Volume:15.52M
Turnover:2.14B
Market Cap:170.23B
PE:20.24
High:141.00
Open:140.43
Low:136.49
Close:141.11
52wk High:157.29
52wk Low:93.37
Shares:1.24B
Float Shares:1.24B
Volume Ratio:2.94
T/O Rate:1.25%
Dividend:3.16
Dividend Rate:2.30%
EPS(TTM):6.78
EPS(LYR):6.78
ROE:40.66%
ROA:12.52%
PB:7.50
PE(LYR):20.24

Loading ...

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Yesterday

Gilead Sciences Says CEO Daniel P. O'day's 2025 Total Compensation Was $28.4 Mln - SEC Filing

THOMSON REUTERS
·
Yesterday

Gilead Sciences Inc. Announces Annual Stockholders Meeting

Reuters
·
Yesterday

Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors

TIPRANKS
·
Yesterday

Assembly Biosciences FY 2025 net loss narrows to USD 6.12 million as collaboration revenue rises 100% to USD 72.3 million

Reuters
·
Mar 20

Gilead Sciences Initiates Phase III Trial for Dual-Target CAR-T Therapy

Stock News
·
Mar 19

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Gilead Sciences Inc Stock (GILD) Moved Down by 3.37% on Mar 18: Facts Behind the Movement

TradingKey
·
Mar 18

Compugen Ltd. director Gilead Halevy files initial beneficial ownership statement

Reuters
·
Mar 18

Gilead Chief Comm & Corp Aff Officer Johanna Mercier disposes of USD 432,690 in common shares

Reuters
·
Mar 18

Gilead CFO Andrew D. Dickinson disposes of USD 432,690 of common shares

Reuters
·
Mar 18

Arcellx shareholders set to receive USD 115 per share in Gilead deal

Reuters
·
Mar 17

Eswatini starts administering lenacapavir to curb spread of HIV

Reuters
·
Mar 17

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals

Simply Wall St.
·
Mar 12

Where Has Wall Street's Institutional Capital Flowed? Bank of America Report Points to AI, with Palantir and Broadcom Leading Inflows

Stock News
·
Mar 12

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 11

Gilead Sciences Initiated at Buy by Jefferies

Dow Jones
·
Mar 10

Gilead : Jefferies Initiates Coverage With Buy Rating; Price Target $180

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 10